vs

Side-by-side financial comparison of ARVINAS, INC. (ARVN) and Pioneer Bancorp, Inc. (PBFS). Click either name above to swap in a different company.

ARVINAS, INC. is the larger business by last-quarter revenue ($41.9M vs $25.0M, roughly 1.7× Pioneer Bancorp, Inc.). Pioneer Bancorp, Inc. runs the higher net margin — 82.1% vs -83.8%, a 165.9% gap on every dollar of revenue. Over the past eight quarters, Pioneer Bancorp, Inc.'s revenue compounded faster (144.9% CAGR vs 10.0%).

Arvinas, Inc. is a clinical-stage biotechnology company focused on developing targeted protein degradation therapies, including PROTAC molecules, to treat cancer and rare diseases. It operates primarily in the U.S. and global biopharma markets, advancing multiple pipeline candidates through clinical trials to address unmet medical needs.

Pioneer Bancorp, Inc. (MD) is a bank holding company operating as the parent entity of Pioneer Bank. It provides a full suite of retail and commercial banking products and services, including deposit accounts, residential and commercial mortgages, consumer loans, and small business financing, primarily serving individual and corporate customers across local communities in Maryland, U.S.

ARVN vs PBFS — Head-to-Head

Bigger by revenue
ARVN
ARVN
1.7× larger
ARVN
$41.9M
$25.0M
PBFS
Higher net margin
PBFS
PBFS
165.9% more per $
PBFS
82.1%
-83.8%
ARVN
Faster 2-yr revenue CAGR
PBFS
PBFS
Annualised
PBFS
144.9%
10.0%
ARVN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ARVN
ARVN
PBFS
PBFS
Revenue
$41.9M
$25.0M
Net Profit
$-35.1M
$3.7M
Gross Margin
Operating Margin
-104.5%
21.3%
Net Margin
-83.8%
82.1%
Revenue YoY
-59.1%
Net Profit YoY
28.7%
EPS (diluted)
$-0.48
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARVN
ARVN
PBFS
PBFS
Q4 25
$25.0M
Q3 25
$41.9M
$24.0M
Q2 25
$24.4M
Q1 25
$188.8M
$22.8M
Q4 24
$59.2M
Q3 24
$102.4M
$22.0M
Q2 24
$76.5M
$20.9M
Q1 24
$25.3M
$21.6M
Net Profit
ARVN
ARVN
PBFS
PBFS
Q4 25
$3.7M
Q3 25
$-35.1M
$4.3M
Q2 25
$6.5M
Q1 25
$82.9M
$5.8M
Q4 24
$-45.1M
Q3 24
$-49.2M
$6.3M
Q2 24
$-35.2M
$3.9M
Q1 24
$-69.4M
$4.7M
Operating Margin
ARVN
ARVN
PBFS
PBFS
Q4 25
21.3%
Q3 25
-104.5%
23.4%
Q2 25
33.3%
Q1 25
37.8%
32.5%
Q4 24
-98.1%
Q3 24
-58.9%
37.2%
Q2 24
-63.4%
24.1%
Q1 24
-329.2%
28.1%
Net Margin
ARVN
ARVN
PBFS
PBFS
Q4 25
82.1%
Q3 25
-83.8%
18.0%
Q2 25
26.4%
Q1 25
43.9%
25.3%
Q4 24
-76.2%
Q3 24
-48.0%
28.7%
Q2 24
-46.0%
107.4%
Q1 24
-274.3%
21.9%
EPS (diluted)
ARVN
ARVN
PBFS
PBFS
Q4 25
$0.16
Q3 25
$-0.48
$0.18
Q2 25
$0.26
Q1 25
$1.14
$0.23
Q4 24
$-0.63
Q3 24
$-0.68
$0.25
Q2 24
$-0.49
$0.15
Q1 24
$-0.97
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARVN
ARVN
PBFS
PBFS
Cash + ST InvestmentsLiquidity on hand
$787.6M
Total DebtLower is stronger
$600.0K
Stockholders' EquityBook value
$564.4M
$323.9M
Total Assets
$844.3M
$2.2B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARVN
ARVN
PBFS
PBFS
Q4 25
Q3 25
$787.6M
Q2 25
Q1 25
$954.3M
Q4 24
$1.0B
Q3 24
$1.1B
Q2 24
$1.2B
Q1 24
$1.2B
Total Debt
ARVN
ARVN
PBFS
PBFS
Q4 25
Q3 25
$600.0K
Q2 25
Q1 25
$700.0K
Q4 24
$800.0K
Q3 24
$800.0K
Q2 24
$900.0K
Q1 24
$900.0K
Stockholders' Equity
ARVN
ARVN
PBFS
PBFS
Q4 25
$323.9M
Q3 25
$564.4M
$314.2M
Q2 25
$314.2M
Q1 25
$660.1M
$310.7M
Q4 24
$561.7M
Q3 24
$586.0M
$303.8M
Q2 24
$600.2M
$296.5M
Q1 24
$609.7M
$289.0M
Total Assets
ARVN
ARVN
PBFS
PBFS
Q4 25
$2.2B
Q3 25
$844.3M
$2.2B
Q2 25
$2.1B
Q1 25
$1.0B
$2.1B
Q4 24
$1.1B
Q3 24
$1.2B
$2.0B
Q2 24
$1.3B
Q1 24
$1.2B
$2.0B
Debt / Equity
ARVN
ARVN
PBFS
PBFS
Q4 25
Q3 25
0.00×
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARVN
ARVN
PBFS
PBFS
Operating Cash FlowLast quarter
$-59.1M
$11.1M
Free Cash FlowOCF − Capex
$-59.2M
FCF MarginFCF / Revenue
-141.3%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
2.97×
TTM Free Cash FlowTrailing 4 quarters
$-361.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARVN
ARVN
PBFS
PBFS
Q4 25
$11.1M
Q3 25
$-59.1M
$3.9M
Q2 25
$5.1M
Q1 25
$-88.9M
$-3.5M
Q4 24
$-84.1M
Q3 24
$-128.0M
$1.9M
Q2 24
$50.3M
$9.0M
Q1 24
$-97.5M
$3.3M
Free Cash Flow
ARVN
ARVN
PBFS
PBFS
Q4 25
Q3 25
$-59.2M
Q2 25
Q1 25
$-89.3M
Q4 24
$-84.4M
Q3 24
$-128.7M
Q2 24
$49.6M
Q1 24
$-97.6M
FCF Margin
ARVN
ARVN
PBFS
PBFS
Q4 25
Q3 25
-141.3%
Q2 25
Q1 25
-47.3%
Q4 24
-142.6%
Q3 24
-125.7%
Q2 24
64.8%
Q1 24
-385.8%
Capex Intensity
ARVN
ARVN
PBFS
PBFS
Q4 25
Q3 25
0.2%
Q2 25
Q1 25
0.2%
Q4 24
0.5%
Q3 24
0.7%
Q2 24
0.9%
Q1 24
0.4%
Cash Conversion
ARVN
ARVN
PBFS
PBFS
Q4 25
2.97×
Q3 25
0.90×
Q2 25
0.78×
Q1 25
-1.07×
-0.61×
Q4 24
Q3 24
0.30×
Q2 24
2.30×
Q1 24
0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons